It’s two years since Novartis got its Cosentyx IL-17 drug approved for the spinal disease ankylosing spondylitis, and the Swiss pharma company has new data that it hopes will allow it to compete ...

The BE RADIANT trial pitted bimekizumab against Novartis’ Cosentyx (secukinumab) in the treatment of adults with moderate-to-severe psoriasis, and according to UCB is the first study to compare ...

'ZDNET Recommends': What exactly does it mean? ZDNET's recommendations are based on many hours of testing, research, and comparison shopping. We gather data from the best available sources ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

PEN Canada is deeply concerned by CTV’s abrupt cancellation of a planned election misinformation segment, following what appears to be pressure from online harassment. Earlier this month, journalist ...

Are you looking for Microsoft Store in: {0}? I would like information, tips and offers about Microsoft Store and other Microsoft products and services. Click here to ...